Trial intelligence / Profile preview

Metformin with Paclitaxel and Carboplatin in Advanced Endometrial Cancer

NCT02065687Phase 3Unknown

Sponsor
GOG Foundation
Start
Mar 2014
Primary completion
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of liquid metformin (Aspargo Labs) in endometrial cancer (EC), sponsored by GOG Foundation. Status: unknown.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

endometrial cancer (EC)

Beyond the preview

Go deeper on NCT02065687.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02065687.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call